Your browser doesn't support javascript.
loading
Safety evaluation of the use of calcineurin inhibitor to prenatal and postpartum women in Japan from a health administrative database.
Yashima, K; Noda, A; Ishikawa, T; Matsuzaki, F; Miyakoda, K; Nishigori, H; Mano, N; Obara, T.
Afiliación
  • Yashima K; Department of Pharmacy, Tohoku Medical and Pharmaceutical University Wakabayashi Hospital, Sendai, Japan.
  • Noda A; Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.
  • Ishikawa T; Department of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Matsuzaki F; Division of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Miyakoda K; Laboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Nishigori H; Department of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Mano N; Division of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Obara T; Clinical & Translational Research Center, Kobe University Hospital, Kobe, Japan.
J Neonatal Perinatal Med ; 16(3): 461-473, 2023.
Article en En | MEDLINE | ID: mdl-37742666
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Neonatal Perinatal Med Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Neonatal Perinatal Med Año: 2023 Tipo del documento: Article País de afiliación: Japón